Skip to main content
Premium Trial:

Request an Annual Quote

NIH to Award $62M in Grants for Biomedical Computing Centers

NEW YORK (GenomeWeb News) – The National Institutes of Health has committed up to $62 million over the next four years to fund a biomedical computing program aimed at creating and supporting a network of computational biology and biomedical informatics centers.

The National Centers for Biomedical Computing program will give grants of up to $2.3 million per year over five years to fund centers that will serve as resources for biomedical and biobehavioral research.

The NCBCs will support research that includes comparative genomics, biomolecular modeling and simulation, image analysis, heterogeneous data integration, clinical trial management, and other informatics research-focused applications.

The centers will provide resources for researchers conducing analysis, modeling, and predictive research using complex biomedical data.

All of the centers will have core responsibilities for implementing and coordinating a national project to develop and improve biomedical computing resources, including development and validation of software, engineering tools, and hardware.

The first round of applications is due Jan. 8. Additional information can be found here.

NIH has previously funded seven such NCBCs with awards in 2004 and 2005.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.